SARS-CoV-2 Vaccines in Patients With Multiple Myeloma

Míreanna comhchosúla

• Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health Workers
  de réir: Evangelos Terpos, et al.
  Foilsithe / Cruthaithe: (2021-07-01)
• Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy Individuals
  de réir: Ioannis Ntanasis-Stathopoulos, et al.
  Foilsithe / Cruthaithe: (2022-07-01)
• Sustained but Declining Humoral Immunity Against SARS-CoV-2 at 9 Months Postvaccination With BNT162b2: A Prospective Evaluation in 309 Healthy Individuals
  de réir: Evangelos Terpos, et al.
  Foilsithe / Cruthaithe: (2022-01-01)
• Recovery of Innate Immune Cells and Persisting Alterations in Adaptive Immunity in the Peripheral Blood of Convalescent Plasma Donors at Eight Months Post SARS-CoV-2 Infection
  de réir: Ioannis V. Kostopoulos, et al.
  Foilsithe / Cruthaithe: (2021-03-01)
• Clinical Application of a New SARS-CoV-2 Antigen Detection Kit (Colloidal Gold) in the Detection of COVID-19
  de réir: Evangelos Terpos, et al.
  Foilsithe / Cruthaithe: (2021-05-01)